Healthcare entrepreneurs are an essential part of the innovation landscape and they play center stage at several of MedCity’s events. At the upcoming MedCity INVEST Digital Health virtual conference September 21-25, held in partnership with Medical Alley, digital health startups will present to judges across four tracks as part of the Pitch Perfect competition.
At MedCity INVEST Digital Health virtual, you’ll hear from leading physician executives, payers, active investors and the most promising digital health startups aiming to solve some of healthcare’s greatest challenges. Click here to see agenda.
These healthcare startups will take part in the chronic disease management and value-based care track. They include:
Cerestil Health has expertise in virtual care for seniors with cognitive impairment (e.g., dementia, stroke, Parkinson’s disease). Its digital health programs engage members with cognitive impairment through their family caregivers to improve family caregiver effectiveness. The programs also use predictive analytics to reduce hospitalizations and costs for members, and increase quality of life for caregivers and members.
CEO: Dirk Soenksen
Headquarters: Carlsbad, CA
Current Health?developed an AI-enabled remote patient management platform to help deliver better, more proactive healthcare.? Its ?FDA-cleared platform continuously monitors certain vital signs and augments this data with medical devices to capture a broad picture of human health?and the patient’s ?symptoms. The technology is designed to help identify those at risk of disease and?proactively alert physicians to potential issues, driving?earlier?intervention and?treatment.
CEO: Christopher McCann
Headquarters: Boston, MA
Lighter Health is a personalized, digital health and nutrition coaching intervention program designed to address chronic disease risk through the adoption of plant-based nutrition programs and clinically-proven health principles.
CEO: Anuj Patel
Headquarters: Cambridge, MA
Limbix is building prescription digital therapeutics to treat adolescent mental health disorders. Its first product, Limbix Spark, is an app designed to treat adolescent depression, a leading cause of disability in youth and a serious public health.
CEO: Ben Lewis
Headquarters: San Francisco, CA
myBiometry is developing a platform to monitor/manage patients with chronic disease using biomarker data from proprietary sensors and ML to identify patients at risk of treatment failure. The company pairs this with clinical oversight, education and coaching to help patients to better manage their disease. The initial focus is asthma where treatment failure occurs in over 11.5 million U.S. patients annually. A single use, disposable sensor and device to track a clinically established biomarker of inflammation in breath is under development.
CEO: Bryan Nolan
Headquarters: Boston, MA
All the sessions will be recorded and will be available to attendees upon request.
Tickets are available for $149.
Picture: kentoh, Getty Images